Cargando…

COVID-19 vaccine prioritisation for type 1 and type 2 diabetes

Detalles Bibliográficos
Autores principales:	Powers, Alvin C, Aronoff, David M, Eckel, Robert H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831734/ https://www.ncbi.nlm.nih.gov/pubmed/33476583 http://dx.doi.org/10.1016/S2213-8587(21)00017-6

Ejemplares similares

COVID-19 vaccine prioritisation for people with disabilities
por: Epstein, Sabrina, et al.
Publicado: (2021)

Who should be prioritised for COVID-19 vaccines?
por: Hassan-Smith, Zaki, et al.
Publicado: (2020)

COVID-19 vaccine prioritisation for individuals with psychoses
por: Kumar, Sonali, et al.
Publicado: (2021)

Considering gender-based violence in vaccine prioritisation strategies
por: Chandan, Joht Singh, et al.
Publicado: (2021)

Water, climate change, and COVID-19: prioritising those in water-stressed settings
por: Armitage, Richard, et al.
Publicado: (2020)

Prioritising immunisation across the life course
por: Saso, Anja, et al.
Publicado: (2021)

Prioritising Causal Genes at Type 2 Diabetes Risk Loci
por: Grotz, Antje K., et al.
Publicado: (2017)

Prioritising immunisation across the life course – Authors' reply
por: Mosser, Jonathan F, et al.
Publicado: (2021)

Prioritise people with HIV for COVID-19 vaccination
por: HIV, The Lancet
Publicado: (2021)

Who should be prioritised for COVID-19 vaccination?
por: Russell, Fiona M, et al.
Publicado: (2020)

New-Onset Diabetes in Covid-19
por: Rubino, Francesco, et al.
Publicado: (2020)

COVID-19 vaccine prioritisation for people with cystic fibrosis
por: Carr, Siobhán B, et al.
Publicado: (2021)

Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK
por: Carr, Matthew J, et al.
Publicado: (2021)

Vaccination as an Equaliser? Evaluating COVID-19 Vaccine Prioritisation and Compensation
por: Günther, Christian, et al.
Publicado: (2022)

Sacral neuromodulation: time to seize the opportunity to collaborate on a ‘de-prioritised’ service?
por: O’Connor, A., et al.
Publicado: (2023)

Exploring the ethics of genetic prioritisation for COVID-19 vaccines
por: Bruce, Jago, et al.
Publicado: (2022)

Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes
por: Dawed, Adem Y., et al.
Publicado: (2017)

COVID-19 Vaccine Prioritisation for Medical Students: The Forgotten Cohort?
por: Lim, J.S., et al.
Publicado: (2021)

The precautions required for the safe return of elective surgery - a letter to the editor in response to “Impact of the coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritisation)ˮ
por: Cheng, Shuliang Oliver, et al.
Publicado: (2020)

Prioritising Risk Factors for Type 2 Diabetes: Causal Inference through Genetic Approaches
por: Wittemans, Laura B. L., et al.
Publicado: (2018)

Effect of the COVID-19 pandemic on body weight in people at high risk of type 2 diabetes referred to the English NHS Diabetes Prevention Programme
por: Valabhji, Jonathan, et al.
Publicado: (2021)

The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation
por: McGovern, Andrew P., et al.
Publicado: (2021)

Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
por: Watchorn, David, et al.
Publicado: (2021)

COVID-19 vaccination and HIV-1 acquisition
por: Logunov, Denis Y, et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Type 2 diabetes and mortality in females versus males in England: the Salford diabetes cohort
por: Heald, Adrian H., et al.
Publicado: (2023)

An intersectional human rights approach to prioritising access to COVID-19 vaccines
por: Sekalala, Sharifah, et al.
Publicado: (2021)

A rationale to prioritise vaccination of HSCT patients against COVID-19
por: Leclerc, Mathieu, et al.
Publicado: (2021)

SARS-CoV-2 — No Increased Islet Autoimmunity or Type 1 Diabetes in Teens
por: Krischer, Jeffrey P., et al.
Publicado: (2023)

Tobacco smoking and type 2 diabetes mellitus in Gulf Cooperation Council Countries
por: Al-Zalabani, Abdulmohsen H., et al.
Publicado: (2021)

Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines
por: Collier, Ai-ris Y., et al.
Publicado: (2021)

Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
por: Cai, Xiaoling, et al.
Publicado: (2022)

Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
por: Hu, Jing-Yi, et al.
Publicado: (2021)

Letter to the Editor: Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Roundtable discussion on the Third Global Symposium on Health Systems Research: why prioritise talk over aid in the midst of the Ebola crisis?
por: Lazarus, Jeffrey V, et al.
Publicado: (2015)

Using observational data to prioritise COVID-19 vaccination strategies: opportunity or necessity?
por: Zaccardi, F., et al.
Publicado: (2021)

Why we should not ‘just use age’ for COVID-19 vaccine prioritisation
por: Smith, Maxwell J
Publicado: (2022)

Covid-19–Associated Myopathy Caused by Type I Interferonopathy
por: Manzano, Giovanna S., et al.
Publicado: (2020)

Prevalence of type-1 interferon autoantibodies in adults with non-COVID-19 acute respiratory failure
por: Ghale, Rajani, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gj15rftrodlp3vim6btcrhvdch